![5-[4-Phenyl-5-(Trifluoromethyl)-2-Thienyl]-3-[3-(Trifluoromethyl)Phenyl]-1,2,4-Oxadiazole](https://static.cymitquimica.com/products/3D/img/FP101657.png "Clique para ampliar")
5-[4-Phenyl-5-(Trifluoromethyl)-2-Thienyl]-3-[3-(Trifluoromethyl)Phenyl]-1,2,4-Oxadiazole
CAS: 256414-75-2
Ref. 3D-FP101657
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado |
Informação sobre produto
Nome:
5-[4-Phenyl-5-(Trifluoromethyl)-2-Thienyl]-3-[3-(Trifluoromethyl)Phenyl]-1,2,4-Oxadiazole
Sinónimos:
- 1,2,4-Oxadiazole, 5-[4-phenyl-5-(trifluoromethyl)-2-thienyl]-3-[3-(trifluoromethyl)phenyl]-
- 5-[4-Phenyl-5-(trifluoromethyl)-2-thienyl]-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole
- 5-[4-Phenyl-5-(Trifluoromethyl)Thien-2-Yl]-3-[3-(Trifluoromethyl)Phenyl]-1,2,4-Oxadiazole
Descrição:
5-[4-Phenyl-5-(Trifluoromethyl)-2-Thienyl]-3-[3-(Trifluoromethyl)Phenyl]-1,2,4-Oxadiazole (5CZD) is a novel synthetic small molecule that acts as a potent and selective inhibitor of the enzyme methyltransferase. 5CZD has been shown to inhibit the activation of the p42/p44 mitogen activated protein kinases (MAPKs) in pancreatic cancer cells. This inhibition was mediated through a Sew2871 dependent mechanism and was associated with an increase in pluripotent stem cells in vitro. 5CZD also inhibited the proliferation of human embryonic stem cells, but not mouse embryonic stem cells, which may be due to its agonistic activity against mouse MAPKs.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
440.36 g/mol
Fórmula:
C20H10F6N2OS
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
